Pronađeno: 31-40 / 345 radova

Autori: Damjanov Nemanja S

>> Filter: Samo Article i Review

Naslov 2019 EULAR points to consider for the assessment of competences in rheumatology specialty training (Review)
Autori Sivera Francisca  ...  Damjanov Nemanja S  ...  (broj koautora 22) 
Info ANNALS OF THE RHEUMATIC DISEASES, (2021), vol. 80 br. 1, str. 65-70
Projekat European League Against Rheumatism
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Hyperbaric Oxygen Therapy and Quality of Life in Patients with Systemic Sclerosis (Meeting Abstract)
Autori Pavlov-Dolijanovic Slavica R  Koletic V  Vujasinovic-Stupar Nada Z  Damjanov Nemanja S 
Info OSTEOPOROSIS INTERNATIONAL, (2020), vol. 31 br. SUPPL 1, Suppl. 1, str. S442-S442
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Longitudinal Change in the Central Nervous System Pain Response After Treatment with Certolizumab or Placebo. a Post-hoc Analysis from the Pre-CEPRA Trial (Meeting Abstract)
Autori Rech Juergen  ...  Damjanov Nemanja S  ...  (broj koautora 25) 
Info ARTHRITIS & RHEUMATOLOGY, (2020), vol. 72 br. , Suppl. 10, str. -
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Brain fMRI Predicts Responses to Certolizumab Pegol in RA. an International, Multi-center, Randomized, Double-blind, Placebocontrolled Trial (PreCePRA) (Meeting Abstract)
Autori Rech Juergen  ...  Damjanov Nemanja S  ...  (broj koautora 25) 
Info ARTHRITIS & RHEUMATOLOGY, (2020), vol. 72 br. , Suppl. 10, str. -
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis with Inadequate Response to Non-Biologic DMARDs Treated with Upadacitinib versus Placebo or Adalimumab: Results from a Phase 3 Study (Meeting Abstract)
Autori Strand Vibeke  Mease Philip  Soriano Enrique  Kishimoto Mitsumasa  Salvarani Carlo  Damjanov Nemanja S  Anderson Jaclyn K  Blondell Erin  Zueger Patrick  Saffore Christopher  Gladman Dafna 
Info ARTHRITIS & RHEUMATOLOGY, (2020), vol. 72 br. , Suppl. 10, str. -
Projekat AbbVie
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate: Results at 84 Weeks (Meeting Abstract)
Autori Smolen Josef S  Emery Paul  Rigby William  Tanaka Yoshiya  Vargas Juan  Damjanov Nemanja S  Jain Manish  Song Yanna  Khan Nasser  Enejosa Jeffrey  Cohen Stanley B 
Info ARTHRITIS & RHEUMATOLOGY, (2020), vol. 72 br. , Suppl. 10, str. -
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries (Article)
Autori Meisters Rachelle  ...  Damjanov Nemanja S  ...  (broj koautora 46) 
Info ANNALS OF THE RHEUMATIC DISEASES, (2020), vol. 79 br. 11, str. 1423-1431
Projekat NIHR Manchester Biomedical Research CentreNational Institute for Health Research (NIHR); Versus ArthritisVersus Arthritis [20380]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov The Relationship Between Tc-99m-Pertechnetate Hand Perfusion Scintigraphy and Nailfold Capillaroscopy in Systemic Sclerosis Patients: A Pilot Study (Article)
Autori Pavlov-Dolijanovic Slavica R  Petrovic Nebojsa S  Vujasinovic-Stupar Nada Z  Damjanov Nemanja S  Radunovic Goran L  Babic Dragan D  Sobic-Saranovic Dragana P  Artiko Vera M 
Info ARCHIVES OF RHEUMATOLOGY, (2020), vol. 35 br. 3, str. 321-327
Projekat Ministry of Education, Science and Technological Development of Serbia [M175018]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate (Article)
Autori Robinson Michael F  Damjanov Nemanja S  Stamenkovic Bojana N  Radunovic Goran L  Kivitz Alan J  Cox Lori  Manukyan Zorayr  Banfield Christopher  Saunders Michael  Chandra Deepa  Vincent Michael S  Mancuso Jessica  Peeva Elena  Beebe Jean S 
Info ARTHRITIS & RHEUMATOLOGY, (2020), vol. 72 br. 10, str. 1621-1631
Projekat Pfizer, Inc.Pfizer
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate (Article)
Autori Robinson Michael F  Damjanov Nemanja S  Stamenkovic Bojana N  Radunovic Goran L  Kivitz Alan J  Cox Lori  Manukyan Zorayr  Banfield Christopher  Saunders Michael  Chandra Deepa  Vincent Michael S  Mancuso Jessica  Peeva Elena  Beebe Jean S 
Info ARTHRITIS & RHEUMATOLOGY, (2020), vol. 72 br. 10, str. 1621-1631
Projekat Pfizer, Inc.Pfizer
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Ispis zapisa u formatu:TXT | BibTeX